Dirk W. Kirsten
Director of Finance/CFO bij MEDARTIS HOLDING AG
Vermogen: 121 776 $ op 29-02-2024
Profiel
Presently, Dirk W.
Kirsten holds the position of Chief Financial Officer of Medartis Holding AG.
In his past career Dr. Kirsten occupied the position of Head-Group Funding & Capital Markets at Roche Holding AG, Chief Financial Officer for Nobel Biocare Holding AG and Group Treasurer at Syngenta AG.
Dr. Kirsten received a doctorate from Universität zu Köln.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
MEDARTIS HOLDING AG
0.01% | 31-12-2022 | 1 477 ( 0.01% ) | 121 776 $ | 29-02-2024 |
Actieve functies van Dirk W. Kirsten
Bedrijven | Functie | Begin |
---|---|---|
MEDARTIS HOLDING AG | Director of Finance/CFO | 01-03-2021 |
Eerdere bekende functies van Dirk W. Kirsten
Bedrijven | Functie | Einde |
---|---|---|
NOBEL BIOCARE HOLDING AG | Director of Finance/CFO | 01-01-2013 |
SYNGENTA | Treasurer | 01-01-2008 |
ROCHE HOLDING AG | Corporate Officer/Principal | 01-01-2004 |
Opleiding van Dirk W. Kirsten
Universität zu Köln | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ROCHE HOLDING AG | Health Technology |
MEDARTIS HOLDING AG | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Syngenta AG
Syngenta AG Chemicals: AgriculturalProcess Industries Syngenta AG specializes in crop protection and seeds production. Its products include selective and non-selective herbicides, fungicides, insecticides, as well as field crop and vegetable seeds. The company was founded on November 12, 1999 and is headquartered in Basel, Switzerland. | Process Industries |
Nobel Biocare Holding AG
Nobel Biocare Holding AG Medical SpecialtiesHealth Technology Nobel Biocare Holding AG is a provider in the field of innovative implant-based dental restorations - from single-tooth to fully edentulous indications. It offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems as well as diagnostics, treatment planning, guided surgery solutions and biomaterials. The company's portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems, a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning and guided surgery solutions and biomaterials. Nobel Biocare Holding was founded in 1981 and is headquartered in Kloten, Switzerland. | Health Technology |